• Corcept Therapeutics CFO Atabak Mokari exercised stock options for 80,000 shares at USD 23.06 on July 30, 2026.
• He sold 79,870 shares the same day in multiple trades priced about USD 105.54 to USD 120.67.
• He held 16,130 shares of common stock following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corcept Therapeutics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-330668), on August 03, 2026, and is solely responsible for the information contained therein.